GGrantIndex
Sort

78,016 grants matching breast cancer

THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASIS

$480,062
Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · R01 · FY2024 · CA

Molecular Diagnostics for Breast Cancer

$480,039
University Of Utah · R33 · FY2003 · CA

Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors

$480,008
Cecile A Lengacher · University Of South Florida · R01 · FY2019 · CA

Mechanisms of Tumor Cell Dormancy and Tumor Recurrence

$480,007
Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

MECHANISMS OF ACTION AND RESISTANCE TO CDK4/6 INHIBITORS IN BREAST CANCER

$480,000
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2018 · Defense Health Agency

Bay Area Tumor Institute CCOP

$480,000
James Feusner · Bay Area Tumor Institute · U10 · FY2007 · CA

TARGETING CRYPTIC SPLICING-DERIVED NEOANTIGENS IN HNRNPM-DYSREGULATED TRIPLE-NEGATIVE BREAST CANCER

$480,000
Baylor College Of Medicine · · FY2025 · Defense Health Agency

Targeting secreted factors in endocrine resistant breast cancer therapy

$480,000
Kideok Jin · Albany College Of Pharmacy · R15 · FY2023 · CA

DISCOVER OF AKT-REGULATED TRANSCRIPTIONAL MODULES ASSOCIATED WITH MALIGNANT PHONOTYPES IN BREAST CANCER

$480,000
The Trustees Of Columbia University In The City Of New York · · FY2012 · Department of the Army

MAIN LINE HEALTH CCOP

$480,000
Paul B Gilman · Lankenau Institute For Medical Research · U10 · FY2007 · CA

Mechanisms of chromatin binding and selection by family IV bromodomains

$480,000
Karen Champagne Glass · Albany College Of Pharmacy · R15 · FY2016 · GM

Solid Phase Microextraction as a New Tool for Quantifying Antibody Drugs in Breast Cancer and Building PK-PD models

$480,000
Florin Marcel Musteata · Albany College Of Pharmacy · R15 · FY2024 · CA

Microendoscopic Electrical Impedance Sensing for Real-time Intraoperative Surgical Margin Assessment

$479,962
Ryan Joseph Halter · Dartmouth College · R01 · FY2023 · CA

Telomeres and lung cancer incidence and survival

$479,954
Jennifer A. Doherty · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA

Targeting Podoplanin to Prevent and Combat Oral Cancer

$479,927
Gary S Goldberg · Rowan University School/Osteopathic Med · R15 · FY2019 · CA

HippoPCI Hippocampal Predictors of Cognitive Impairment in Breast Cancer Patients

$479,886
Lei Wang · Northwestern University At Chicago · R01 · FY2014 · NR

IBCSG Statistical Center - A Breast Cancer Study Resource

$479,872
Meredith M Regan · Dana-Farber Cancer Inst · U24 · FY2015 · CA

Atlanta Regional Community Clinical Oncology Program

$479,841
Thomas E Seay · St. Joseph'S Hospital · U10 · FY2006 · CA

Molecular Analysis of Human Breast Cancer

$479,837
Georgetown University · R01 · FY2005 · CA

TAMOXIFEN--RISK OF MI, STROKE AND VENOUS THROMBOEMBOLISM

$479,833
University Of Southern California · R01 · FY2001 · CA

Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients

$479,816
Jennifer Lynne Huberty · University Of Texas Hlth Science Center · R01 · FY2022 · CA

The nuclear Ferredoxin reductase and its role in tumor suppression

$479,793
Xinbin Chen · University Of California At Davis · R01 · FY2025 · CA

Transcriptional regulation of mammary gland development

$479,688
Eran Robert Andrechek · Michigan State University · R01 · FY2023 · HD

Mammary basal/stem cell plasticity and regulation

$479,675
Xing Dai · University Of California-Irvine · R01 · FY2019 · GM

HRT USE AND RISK OF LOBULAR AND DUCTAL BREAST CANCER

$479,668
Fred Hutchinson Cancer Research Center · R01 · FY2000 · CA